CLINIMACS CELL FACTORY
Miltenyi Biotec GmbH
Trademark Registered: 2021-01-12
Trademark Application Details
NEW APPLICATION - ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79279344 |
| Registration Number | 6242135 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Law Office Assigned | M80 |
| Employee Name | LEASER, ANDREW C |
Timeline
| 2019-10-10 | Application Filed |
| 2020-02-25 | Location: TMO LAW OFFICE 117 |
| 2020-02-25 | Status: Live/Pending |
| 2020-02-25 | Transaction Date |
| 2021-01-12 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Miltenyi Biotec GmbH |
| Address | Friedrich-Ebert-Str. 68 51429 Bergisch Gladbach DE |
| Legal Entity Type | Gesellschaft Mit Beschränkter Haftung (gmbh) |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 9 |
| U.S. Codes: | 021,023,026,036,038 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0011 | Chemicals and/or biological preparations for use in industry and science; diagnostic preparations for scientific or research use including medical diagnosis, chemicals, biological and biochemical preparations for use in separation processes for biological materials, in particular nucleic acid; reagents for cell separation, labelling reagents; chemicals for use in separation processes for biological materials; molecules of microorganisms including viruses, bacteria, fungi, in particular proteins, peptides, and protein and peptide pools, oligosaccharides, lipids, hybridisation solutions, cleaning solutions, cDNA clones, all for use in industry and science; reagents, chemical and/or biological media, materials and components for preparing media, all of the aforesaid for industrial and scientific purposes and for use in medical laboratories, included in this class; reagents for use in science and/or industry for processing, separating, isolating, enriching, expanding, differentiating, depleting, detecting, screening, analysing and tallying material, in particular chemicals and biological material, reagents featuring magnetic beads, antibody reagents; buffer solutions and reagents for use with laboratory apparatus, in particular separation apparatus, analysers, reactors, cell processing apparatus and imaging apparatus; reagents for use in science and/or industry for processing biological material, in particular tissues, bone marrow, cells, blood and components thereof; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; chemical reagents and preparations for use in the manufacture of medicines; culture media, cell culture media, freezing media for in vivo scientific use; reagents for use in biotechnology, in biological processing operations and in the biotechnology industry, and medicine production; chemicals and biological preparations for use in industry and science; diagnostic preparations for scientific or research use; chemical and/or biological substances and mixtures for industrial and scientific applications in preparing media; culture media for biology, microbiology and for use in the biotechnical industry and in medicine; chemical preparations for use in pharmaceutical, medical and veterinary science; reagents for clinical and non-clinical laboratory use, in particular cytokines and antibodies |
| D10000 | "CELL FACTORY" |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2020-02-20 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-02-25 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2020-02-25 | 3 DOCK D:Assigned to Examiner |
| APPLICATION FILING RECEIPT MAILED | 2020-02-29 | 4 MAFR O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2020-03-03 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2020-03-04 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2020-03-24 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2020-03-24 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2020-04-10 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-05-06 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-05-06 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-05-07 | 12 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2020-05-27 | 13 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2020-05-27 | 14 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-05-27 | 15 GNRN O:Outgoing Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2020-06-06 | 16 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2020-06-06 | 17 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2020-06-06 | 18 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2020-06-06 | 19 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-06-22 | 20 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-07-08 | 21 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2020-07-15 | 22 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2020-07-15 | 23 OPNS P: |
| PUBLISHED FOR OPPOSITION | 2020-07-28 | 24 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-07-28 | 25 NPUB E:E-Mail |
| NOTIFICATION PROCESSED BY IB | 2020-07-31 | 26 GPNX P: |
| WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST | 2020-08-29 | 27 ISSR Z:Deletion |
| PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2020-09-03 | 28 ZZZX Z:Deletion |
| EXAMINERS AMENDMENT -WRITTEN | 2020-09-03 | 29 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2020-09-03 | 30 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2020-09-03 | 31 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2020-09-03 | 32 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-09-03 | 33 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2020-09-16 | 34 ALIE A:Allowance for Publication |
| CHANGE OF OWNER RECEIVED FROM IB | 2020-09-18 | 35 CHLD M: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2020-09-23 | 36 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-10-07 | 37 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2020-10-07 | 38 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2020-10-07 | 39 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2020-10-25 | 40 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2020-10-27 | 41 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-10-27 | 42 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2021-01-12 | 43 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2021-04-12 | 44 FICR P: |
| FINAL DISPOSITION PROCESSED | 2021-04-19 | 45 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2021-04-19 | 46 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2021-05-11 | 47 FINO P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 